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Abstract
Background: Although it is well known that renal artery stenosis may cause renovascular hypertension, it is unclear
how the degree of stenosis should best be measured in morphological images. The aim of this study was to determine
which morphological measures from Computed Tomography Angiography (CTA) and Magnetic Resonance
Angiography (MRA) are best in predicting whether a renal artery stenosis is hemodynamically significant or not.
Methods: Forty-seven patients with hypertension and a clinical suspicion of renovascular hypertension were examined
with CTA, MRA, captopril-enhanced renography (CER) and captopril test (Ctest). CTA and MRA images of the renal
arteries were analyzed by two readers using interactive vessel segmentation software. The measures included
minimum diameter, minimum area, diameter reduction and area reduction. In addition, two radiologists visually judged
the diameter reduction without automated segmentation. The results were then compared using limits of agreement
and intra-class correlation, and correlated with the results from CER combined with Ctest (which were used as standard
of reference) using receiver operating characteristics (ROC) analysis.
Results: A total of 68 kidneys had all three investigations (CTA, MRA and CER + Ctest), where 11 kidneys (16.2 %) got a
positive result on the CER + Ctest. The greatest area under ROC curve (AUROC) was found for the area reduction on
MRA, with a value of 0.91 (95 % confidence interval 0.82–0.99), excluding accessory renal arteries. As comparison, the
AUROC for the radiologists’ visual assessments on CTA and MRA were 0.90 (0.82–0.98) and 0.91 (0.83–0.99) respectively.
None of the differences were statistically significant.
Conclusions: No significant differences were found between the morphological measures in their ability to predict
hemodynamically significant stenosis, but a tendency of MRA having higher AUROC than CTA. There was no significant
difference between measurements made by the radiologists and measurements made with fuzzy connectedness
segmentation. Further studies are required to definitely identify the optimal measurement approach.
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Background
Renal artery stenosis (RAS), most commonly due to ath-
erosclerosis, is an important cause of hypertension and
accounts for 1–5 % of all hypertension cases in the gen-
eral population, but when at-risk patients are identified
through clinical selection criteria, the estimated preva-
lence of renovascular-induced hypertension increases to
20–40 % [1]. Currently, there is much debate over how
to best treat these patients and the value of percutan-
eous transluminal renal angioplasty (PTRA) in renal
artery stenosis is not completely known [2, 3]. The re-
cently published CORAL study even found that renal
artery stenting does not significantly improve clinical
outcome [4]. It is therefore important to have reliable
diagnostic methods in order to identify patients that
could benefit from treatment.
The most commonly available methods to diagnose RAS
are computed tomography angiography (CTA), magnetic
resonance angiography (MRA), captopril-enhanced renog-
raphy (CER), captopril test (Ctest), ultrasonography and
invasive intra-arterial renal angiography (IARA) [1]. IARA
has long been considered the gold standard for diagnosing
RAS [5], but it is not an ideal method. It relies strictly on
lumen morphology and thus gives only indirect informa-
tion about the hemodynamic consequences of the stenosis
[6]. Besides, the invasive nature also means a risk of severe
complications [7–10]. It can sometimes be combined with
measurement of the pressure drop through the stenosis,
which may indicate more reliably hemodynamically signifi-
cant RAS [11], although the presence of a catheter in the
artery might disturb the measurements [12]. Rapid pro-
gress in spatial resolution and image quality has allowed
MRA and CTA to replace the invasive examinations as the
standard diagnostic methods [1, 13]. Although a major
prospective study, conducted between 1998 and 2001 and
published in 2004 (the RADISH-trial), concluded that nei-
ther CTA nor MRA are reproducible or sensitive enough
to replace IARA as the diagnostic gold standard [14], ran-
domized trials comparing CTA and MRA to IARA have
shown a sensitivity of 94–95 % and a specificity of 92–
93 % for CTA [15, 16], and a sensitivity of 90–100 % and a
specificity of 94–98 % for MRA [15, 17].
Renography is a method for functional evaluation of
the kidney. The use of angiotensin converting enzyme
(ACE) inhibitors, such as captopril, in conjunction with
radionuclide renography has been shown to enhance
sensitivity and specificity for detecting renovascular
hypertension [18, 19]. CER has been reported to have a
sensitivity of 87–95 % and specificity of 93–100 % when
the reference is whether there is a reduction in blood
pressure following intervention [20, 21]. That makes
CER a valuable method for detecting hemodynamically
significant stenoses. However, in cases with potential
bilateral stenosis, as well as in severe renal failure, its
value is doubtful [19]. In cases of intermediate test re-
sults on CER, the captopril test (Ctest), which includes
analysis of the plasma concentration of renin before and
after ingestion of captopril, has been applied to strengthen
the diagnosis [6].
The advances of computer post-processing techniques
enable researchers to obtain detailed quantitative informa-
tion about different morphological measures of the ves-
sels, such as minimum diameter, diameter reduction,
minimum area and area reduction, from CTA and MRA.
A diameter reduction of >50 % has been considered
hemodynamically significant by many authors [13, 22, 23],
whereas others have advocated higher threshold values
[24], but this is not necessarily equivalent to a decrease in
function of one or both kidneys [6]. There is therefore a
need to investigate how to measure RAS on MRA and
CTA to find the best predictive measure of the
hemodynamic significance of the stenosis. Although
Schoenberg et al. have shown that measurements of the
area of the stenosis on MRA might be a better predictor
of hemodynamically significant stenosis than the diameter
[23], there is not much information about how different
morphological measures correlate with renal functional
tests. Thus, the aim of our study was to compare different
morphological measurements describing renal artery sten-
oses in CTA and MRA images with respect to their ability
to predict a hemodynamically significant stenosis as de-
fined by captopril-enhanced renography.
Methods
Patients
For this study, the patient material from an earlier study
[6] was used. The ethical approval of the acquisition of
data for the original publication was given by the re-
gional research ethics committee in Linköping, Sweden
(decision nr. 03–412 and M90-05, dated Nov. 4, 2003
and Aug. 10, 2005). Written informed consent was ob-
tained from each patient before examination, and the
study was performed in compliance with the Helsinki
Declaration. Forty-seven patients of both genders, 18–80
years old, with a screening serum creatinine of 150–
300 μmol/L, hypertension and clinical suspicion of reno-
vascular hypertension were consecutively recruited for
the study and examined with MRA, CTA, CER and
Ctest. Inclusion and exclusion criteria as well as demo-
graphic characteristics are described in [6].
Morphological investigations
The imaging technique for the CTA and MRA exami-
nations has been published previously [6]. The acqui-
sition protocol for CTA specified a voxel size of
0.75×0.5×0.5 mm3, and that for MRA a voxel size of
2.0×0.7×0.7 mm3. However, in eight of the patients,
CTA data with a higher slice thickness of up to
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3 mm had to be used, due to incomplete archiving.
In one case, CTA data were missing.
Evaluation of CTA and MRA data was made with
OsiriX (v.3.6.1 32-bits) [25] and the semi-automated
CTA plug-in (CMIV CTA tools) [26] (Fig. 1a and b).
The plug-in uses a competing fuzzy-connectedness tree
algorithm to segment vessels and extract vessel center-
lines [27]. The studied arteries were visualized using
curved plane reformatting and the measurements were
performed with in a cross-section view of the vessel. The
vessel cross-sections were automatically segmented
using a thresholding-based level-set method [28]. Some
parameters that had to be set in the algorithm were se-
lected after testing and visually assessing the results of
alternative settings. The curvature scale was set to 10 to
eliminate the effects of noise and keep the vessel contour
smooth. A lower threshold (LT) value had to be defined
for both MRA and CTA, and for CTA, an upper threshold
(UT) was also needed, since calcified plaques have an
attenuation exceeding that of contrast-mixed blood.
The LT was set using a grey-scale value in between the
value contrast agent and background. The value of con-
trast agent was determined by measuring the maximum
values of ROIs in aorta. The final value is calculated as the
mean values from three cross-sections of the aorta (the
cross-section of the abdominal aorta giving the greatest
mean value and the corresponding slices 10 mm proximal
and 10 mm distal to the maximum value). A background
grey-scale value was determined by measuring the mean
value of ROIs in non-contrast-filled areas. In CTA, four
regions of interests (ROIs) were placed in the psoas mus-
cles, and in MRA, three ROIs were placed in the vertebral
bodies. For both modalities, the LT was then calculated
for each patient with the formula LT = (aorta + 2*back-
ground)/3, which visually was the most reliable in a pilot-
group of seven patients. The UT for CTA was calculated
as the mean value of the maximum value of the cross-
section slices of the abdominal aorta and the correspond-
ing maximum values 10 mm proximal and 10 mm distal
to the maximum value.
The CMIV CTA tools of the OsiriX software was in
most cases able to automatically define the centerline of
the vessel. When not possible, or when the automatically
created centerline was obviously false, the centerlines
had to be drawn manually.
Two segments in each renal artery were measured.
The first segment was limited by the aorta and the most
proximal bifurcation, while the second segment was de-
fined as the largest branch from the first bifurcation to
the second bifurcation. In each segment, the minimum
diameter (MinD), the minimum area (MinA), the max-
imum diameter (MaxD) and the maximum area (MaxA)
were measured and the relative diameter reduction
(Dred) was calculated as
Dred ¼ ð1−MinD=MaxDÞ  100%
and the relative area reduction (Ared) was calculated as
Ared ¼ ð1−MinA=MaxAÞ  100%
To make sure that the MaxD and the MaxA were not
affected by the bifurcation geometry, rules were set pro-
hibiting the readers from measuring the MaxD and
MaxA (i) less than 10 mm from the aorta and (ii) less
than 5 mm proximal or distal to a bifurcation. When the
rules made it impossible to measure the maximum
values (e.g. in cases with very short distances between
the branches) they were visually obtained.
The measurements of the renal arteries were made by
two medical students, each blinded for the other’s result
and for the results of the other modalities. The morpho-
logical measures were calculated as the mean value of
the two reader’s observations, except for the analysis of
the inter-observer agreement. In those cases where only
one reader considered a segment measurable, that reader’s
measurements were used.
Since two segments were measured in each artery, and
each kidney might have more than one artery, several
measurements were obtained from each kidney. How-
ever, for correlation with the CER + Ctest, only one seg-
ment had to be chosen. Three different measurement
approaches were used to summarize the results from the
two segments of each artery to only one result for the
whole kidney (i) the most pronounced stenosis (defined
as the segment with the largest Dred) in the first seg-
ment, or first segments if the patient had accessory renal
arteries (referred to as First), (ii) the most pronounced
stenosis in any segment on one side (Tightest), and (iii)
the most pronounced stenosis in the main artery (the ar-
tery with the largest maximum diameter) (Main).
Visual assessment was performed by two radiologists
with at least 20 years of clinical experience [6]. The de-
gree of stenosis was defined for both CTA and MRA on a
six-grade scale: normal, diameter reduction >10 % but ≤
30 %, diameter reduction >30 % but ≤ 50 %, diameter
reduction >50 % but ≤ 70 %, diameter reduction >70 %,
and occlusion. Those results were obtained from the pre-
vious study [6].
Functional investigations
The result from the CER + Ctest was considered to be
the reference for defining hemodynamically significant
stenoses. A 2-day protocol with a baseline renogram
Day 1 and a captopril-stimulated renogram Day 2 was
followed [6]. The interpretation of the CER was based
on the criteria in [19]. Six patients got an intermediate
test result on the CER. In those cases, adding the result
of a Ctest made the final interpretation [6]. Two of the 6
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Fig. 1 a, b. A view of the left renal artery in the OsiriX CTA plug-in from CT angiography (a) and MR angiography (b). In both images, the upper
left part is a graph where the vertical axis represents the shortest cross-section diameter in the selected vessel and the horizontal axis represents the
distance from the start of the vessel. The upper right part is a cross-section view of the marked position in the graph (in these cases the smallest
minimum diameter), the lower left part is a coronal section showing the aorta, the renal arteries and surrounding tissues and the lower right part
is the curved plane reformatted view of the chosen left renal vessel. Both modalities show the same stenosis, but it is more accentuated on the
CT angiography
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intermediate results were judged positive after the Ctest,
and 4 were considered negative.
Statistics
For descriptive purposes, the mean and standard devi-
ation (SD) were used. The inter-observer agreement re-
fers to the difference between the two readers’ results
for the same morphological measurement. It was calcu-
lated from all vessels judged measurable by both readers.
The inter-method agreement refers to the difference
between the mean value of the two readers’ CTA mea-
surements and the mean value of the two readers’ MRA
measurements. It was calculated at kidney level using
the three different measurement approaches described
above. The inter-observer and inter-method agreement
was described as the 95 % limits of agreements (the
mean value of the difference ± 2 SD [29]. In addition, the
intraclass correlation (ICC) was computed, treating both
cases (kidneys or vessels) and observers as random
effects [30]. All these calculations were made with SPSS
19.0.0 (SPSS Inc., Chicago, IL, USA).
To evaluate the morphological methods’ ability to pre-
dict hemodynamically significant stenosis as defined by
the CER + Ctest, receiver operating characteristic curves
(ROC curves) were created for each measurement, as well
as for the radiologists’ measurement from the previous
study, using the statistical software JMP 9.0 (SAS Inc.,
Cary, NC, USA). The areas under the ROC curves (AUR-
OCs) of the different measurements in relation to the
CER +Ctest were compared using Stata 10.1 (StataCorp,
College Station, TX, USA).
Results
In the 47 patients, where 16 patients had more than one
artery per kidney, 104 first segments and 99 second seg-
ments of the arteries were considered measurable (by at
least one observer) for CTA, and for MRA, 92 first seg-
ments and 68 second segments were considered measure-
able. For CTA, 92 % of the measurable first segments
(n = 96), and 73 % of the second segments (n = 72) were
considered measurable by both readers, and for MRA,
90 % of the measureable first segments (n = 83) and 67 %
of the second segments (n = 46) were considered measur-
able by both readers. The mean values and the standard
deviations of the measured segments at artery level are
given in Table 1. In general, both the absolute measures
(MinD an MinA) and the relative measures (Dred and
Ared) gave roughly similar values regardless of whether
they were computed from CTA or MRA images.
Our material consisted of 47 patients, hence 94 kidneys.
Only patients who had all three investigations (MRA,
CTA and CER + Ctest) were included. Eleven kidneys got
a positive result on the CER + Ctest, and the kidneys
contralateral to the positive results were excluded since
the method is unable to give useful information in such
cases. Four kidneys were excluded because their vessels
were non-measurable on either CTA or MRA. One of the
kidneys that were non-measureable on MRA had a posi-
tive result on the CER + Ctest and the contralateral kidney
was thereby excluded. Thus, the analyses were made on
68 kidneys, where 11 kidneys (16.2 %) had a positive result
on the CER +Ctest and 57 kidneys (83.8 %) had a negative
result. The mean values and standard deviations of the
vascular morphology measures for the 68 kidneys using
the three different measurement approaches are found in
Table 1. Again, no obvious difference was found between
CTA and MRA. The smallest MinD and MinA and lar-
gest Dred and Ared were found for both CTA and
MRA in the Tightest approach, while the largest MinD
and MinA and smallest Dred and Ared were found with
the First approach.
Inter-observer agreement
The inter-observer differences in the measurements
from CTA and MRA are shown in Table 2. There was
excellent agreement for all measurements in the first
segment (ICC values between 0.91 and 0.98), while the
agreement was lower for the second segment (ICC
values between 0.48 and 0.87). For each measurement,
the agreement was significantly higher for the first seg-
ment than for the second segment. On CTA and on the
first segment in MRA there seems to be no systematic
under- or overestimation by any reader, but on the MRA
of the second segment, the negative mean differences
between reader 1 and reader 2 imply that reader 2 mea-
sured more severe stenoses than reader 1. Figure 2
shows Bland-Altman plots illustrating the difference in
agreement between the two segments, here shown for
MRA Ared.
Inter-method agreement
The inter-method analysis was made using the 68 vessels
that were compared with the CER + Ctest. The result of
the statistical analysis of the agreement between CTA
and MRA is shown in Table 3. Although all measure-
ments have an excellent agreement, there is generally a
higher agreement for the measurements of the area than
for the measurements of the diameter, with the highest
ICC being found for MinA of First. For all measurement
approaches, Dred, which is the traditionally most used
measure, has the lowest agreement. When comparing
the three measurement approaches, the agreement is
generally highest for First and lowest for Tightest.
Comparison of morphological and functional
investigations
There was a tendency of MRA having higher predictive
ability (AUROC) than CTA (Table 4); however, there were
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no significant differences between them. The highest
AUROC of all measurements made with the computer-
assisted vessel analysis tool was found for Ared on Main
in MRA (0.91) and the highest value for CTA was found
for the Dred on Main (0.88). The lowest AUROC was
found for MinA and Ared on CTA in Tightest (0.81), while
the lowest AUROC for MRA was Dred in First (0.84). For
the radiologists’ visual assessment on a six-grade ordinal
scale, the AUROC were 0.90 for CTA and 0.91 for MRA.
The absolute measures had highest AUROC in First while
the relative measures had the highest AUROC in Main.
Ared had higher AUROC than Dred for MRA, but lower
on the CTA. There were no significant differences be-
tween any of the AUROC values.
Discussion
A central finding in this study is the excellent ICC values
for the inter-method agreement and for the inter-observer
agreement of the first segments, which indicate good
reproducibility for measuring RAS with the computer-
assisted vessel analysis tool. The high reproducibility is
probably due to the low influence of individual arbitrari-
ness because of the highly automated work-flow. The for-
mula for the threshold values, the well-defined measuring
rules, the automatically generated vessel centerlines and
the use of the graph in the CMIV CTA plug-in all make it
easy to extract the minimum and maximum values.
As the differences in AUROC were not significant, it
cannot be concluded whether measurements from the
software tool or visual assessments by radiologists are the
best predictors of a hemodynamically significant stenosis.
In spite of a tendency for AUROC in general being higher
for the visually assessed measurements than for the
computer-assisted vessel analysis tool, there were no, or
only slight, differences when the best measures with the
software on MRA and CTA were used in comparison with
Table 1 Descriptive statistics of stenosis measurements (Mean ± SD). Most prominent stenosis defined in three different ways: most
pronounced stenosis in proximal vessel segment (First), segment with most pronounced stenosis (Tightest) and most pronounced
stenosis in main renal artery (Main)
Modality Measure All arteries Most prominent stenosis for each kidney
Segment 1 Segment 2 First Tightest Main
CTA MinD (mm) 2.65 ± 1.46 2.82 ± 1.01 2.93 ± 1.55 2.68 ± 1.44 2.79 ± 1.35
MinA (mm2) 10.56 ± 8.41 9.49 ± 6.08 12.61 ± 9.05 10.86 ± 7.84 11.24 ± 7.55
Dred (%) 46.7 ± 25.5 24.7 ± 14.7 44.8 ± 26.2 48.4 ± 24.9 46.3 ± 23.2
Ared (%) 58.4 ± 25.5 36.3 ± 17.6 55.5 ± 26.0 59.3 ± 24.0 57.7 ± 22.9
n 96 72 68 68 68
MRA MinD (mm) 2.88 ± 1.76 2.78 ± 1.37 3.06 ± 1.74 2.62 ± 1.64 2.64 ± 1.62
MinA (mm2) 11.63 ± 9.49 9.66 ± 7.01 12.90 ± 9.61 10.54 ± 8.53 10.58 ± 8.49
Dred (%) 45.4 ± 30.8 33.1 ± 25.5 43.6 ± 29.3 50.2 ± 28.2 49.2 ± 27.6
Ared (%) 55.8 ± 29.4 44.1 ± 25.9 53.3 ± 28.1 60.0 ± 26.0 59.3 ± 25.5
n 83 46 68 68 68
Table 2 The inter-observer agreement of morphological measures described as the mean difference Reader 1 – Reader 2 and the 95 %
limits of agreement (mean –2SD; mean + 2SD), as well as the intraclass correlation and its 95 % confidence limits, n = 68
Measure Segment 1 Segment 2
Mean difference (95 %
limits of agreement)
Intraclass correlation (95 %
confidence limits)
Mean difference (95 %
limits of agreement)
Intraclass correlation (95 %
confidence limits)
CTA MinD (mm) −0.11(−1.09; 0.86) 0.97 (0.95–0.98) −0.11(1.57; 1.35) 0.86 (0.78–0.92)
CTA MinA (mm2) 0.08(−5.68; 5.83) 0.97 (0.95–0.98) −0.48(−9.27; 8.31) 0.87 (0.80–0.92)
CTA Dred (%) 2.46(−22.08; 26.99) 0.94 (0.91–0.96) 2.40(−31.10; 35.90) 0.57 (0.32–0.73)
CTA Ared (%) −2.03(−33.01; 28.94) 0.91 (0.86–0.94) −1.91(−41.02; 37.19) 0.64 (0.42–0.78)
MRA MinD (mm) −0.07(−1.16; 1.03) 0.97 (0.96–0.98) 0.15(−2.32; 2.63) 0.70 (0.47–0.84)
MRA MinA (mm2) −0.23(−8.25; 7.79) 0.95 (0.93–0.97) 0.40(−10.52; 11.32) 0.76 (0.57–0.87)
MRA Dred (%) 0.97(−17.65; 19.59) 0.98 (0.96–0.98) −6.90(−64.87; 51.07) 0.48 (0.08–0.71)
MRA Ared (%) −0.58(−16.81; 15.64) 0.98 (0.97–0.99) −8.35(−64.59; 47.90) 0.54 (0.19–0.74)
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the visually assessed measurements (0.91 vs. 0.91 for
MRA and 0.88 vs. 0.90 for CTA). It is, however, interesting
to notice that users without extensive training (medical
students) using the computer-assisted vessel analysis tool
were able to attain AUROC values very close to those of
the visual assessments of experienced radiologists. Since
the influence of individual arbitrariness is minimized
when measuring renal arteries with the standardized algo-
rithm in a much automated process, the level of education
may be a minor problem for obtaining adequate results.
Also, with an excellent inter-observer agreement for the
first segments and an excellent inter-method agreement,
the reproducibility for the method appears satisfactory.
The good reproducibility and AUROCs fairly similar to
the radiologists’ measurements suggest that computer-
assisted vessel segmentation is a promising method for
analyzing RAS, even though definite conclusions about
the clinical utility cannot be drawn.
Fig. 2 a, b. Bland-Altman plots showing the agreement between the two readers (R1 and R2) for Ared in MR angiography for the first (a) and second
(b) segment. The agreement is highest for the first segment as it has the narrowest limits of agreement
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As mentioned earlier, the inter-observer agreement
was excellent for the first segments, but it was consider-
ably lower for the second segments. The inter-method
agreement was also lower for the second segment as the
highest ICC-value was found in First, which is the only
measurement approach that excludes the second seg-
ments. One reason might be that the second segment
was defined as the largest branch from the first bifur-
cation to the second bifurcation, and in some cases it
was not obvious which branch was the largest. This
might lead to the two readers measuring different seg-
ments, which could lead to a lower agreement. One
might speculate that if the second segments were ex-
cluded, the measurements would be more accurate and
therefore have a higher correlation with the functional
evaluation. However, the highest AUROC was found in
Main, which includes the second segment. This suggests
that despite being more difficult to measure, the most
relevant measurements are those that include the second
segment (Main and Tightest rather than First).
Since there were no significant differences between
any of the morphological measures in their ability to
predict a hemodynamically significant stenosis, no defin-
ite conclusions can be drawn. However, a tendency of
MRA having higher AUROC than CTA was found, but
further studies are required to verify this finding. One
explanation might have been that one method systemat-
ically measured more distinct stenoses than the other;
for instance, gadolinium-enhanced MRA is considered
to overestimate the degree of RAS [23]. However, since
Table 4 shows that there are no systematic differences
between CTA and MRA, this does not seem as a likely
explanation of our findings. Our impression is that CTA
yielded the best spatial resolution but had inferior
image-to-noise characteristics, which may be related to
X-ray attenuation in surrounding abdominal organs.
This might be a possible explanation for tendency to
lower AUROC for CTA than for MRA. The lack of sig-
nificant differences between the morphological measures
might indicate that there are no major differences be-
tween them, but the fact that we found that Ared has
the highest AUROC for MRA is in line with the previous
result from Schoenberg et al. who have suggested that
the cut-off value for a hemodynamically significant renal
artery stenosis can be better defined on MRA by meas-
uring the area of the stenosis instead of the diameter
[23]. In the coronaries, Zhang et al. found area reduction
to be superior to diameter reduction in predicting nu-
merically computed fractional flow reserve [31]. For
CTA, on the other hand, the area seems to have a lower
concordance with CER + Ctest than the diameter. There
is not much information available on the reliability of
the different measures on CTA, and, for both modalities,
due to the lack of significant results, no definite conclu-
sions can be drawn.
The purpose of applying three different measurement
approaches was to investigate whether it is of any im-
portance which segments are included in the measure-
ments. Of the three approaches, the maximum AUROC
for both CTA and MRA was found for Main, and the
minimum AUROC was found for Tightest. Tightest and
Main are fairly similar with the only difference being
that Tightest, in cases of more than 1 artery per kidney,
also takes the smaller arteries in account. This result
might indicate that stenoses in the main arteries are
more crucial than stenoses in smaller arteries, or in
other words, a stenosis in a small accessory artery may
not affect whole kidney function enough to be detected
by CER + Ctest. Another possible explanation is that the
Table 3 The inter-method agreement of morphological measures
described as the mean difference of Reader 1 – Reader 2 and the
95 % limits of agreement (mean –2SD; mean + 2SD), as well as
the intraclass correlation and its 95 % confidence limits. n = 68
Measure Mean difference (95 %
limits of agreement)
Intraclass correlation (95 %
confidence limits)
MinD first −0.14(−2.30; 2.03) 0.88 (0.80–0.93)
MinA first −0.29(−9.85; 9.27) 0.93 (0.89–0.96)
Dred first 1.25(−40.31; 42.81) 0.84 (0.74.0.90)
Ared first 2.12(−29.95; 34.20) 0.90 (0.84–0.94)
MinD tightest 0.06(−2.30; 2.43) 0.83 (0.73–0.90)
MinA tightest 0.32(−10.46; 11.09) 0.88 (0.81–0.93)
Dred tightest −1.83(−44.20; 40.53) 0.81 (0.70–0.88)
Ared tightest −0.63(−33.58; 32.32) 0.88 (0.80–0.93)
MinD main 0.15(−2.04; 2.34) 0.84 (0.75–0.90)
MinA main 0.66(−9.55; 10.87) 0.89 (0.82–0.93)
Dred main −2.93(−42.29; 36.42) 0.83 (0.72–0.89)
Ared main −1.60(−32.80; 29.60) 0.89 (0.81–0.93)
Table 4 Relationship between the morphologic measures and
the CER + Ctest expressed as the area under the ROC curve
(95 % confidence interval), n = 68
Measure First Tightest Main
CTA MinD 0.86 (0.77–0.95) 0.83 (0.71–0.94) 0.86 (0.76–0.96)
CTA MinA 0.86 (0.77–0.95) 0.81 (0.70–0.93) 0.84 (0.74–0-95)
CTA Dred 0.85 (0.76–0.95) 0.84 (0.73–0.95) 0.88 (0.78–0.98)
CTA Ared 0.83 (0.71–0.95) 0.81 (0.67–0.95) 0.83 (0.70–0.97)
MRA MinD 0.90 (0.81–0.99) 0.87 (0.77–0.98) 0.88 (0.78–0.99)
MRA MinA 0.90 (0.80–0.99) 0.87 (0.76–0.98) 0.88 (0.77–0.99)
MRA Dred 0.84 (0.70–0.99) 0.88 (0.78–0.98) 0.89 (0.80–0.99)
MRA Ared 0.86 (0.73–0.99) 0.89 (0.81–0.99) 0.91 (0.82–0.99)
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larger main arteries are easier to measure as their larger
size lead to more accurate measurements.
A common reference when calculating Dred and Ared
seems to be the North American Symptomatic Carotid
Endarterectomy Trial (NASCET) criteria [32], which
uses a normal vessel segment distal to the stenosis in-
stead of the widest part of the segment, thereby exclud-
ing a possible post-stenotic dilatation. Although initially
developed for the carotid arteries, it has also been used
for measuring the renal arteries [33]. A difficulty with
that approach might be that a post-stenotic dilatation
extends all the way to the next bifurcation. Another used
reference is the diameter and area of the main renal
artery immediately proximal to the first bifurcation [34].
In this study, the maximum diameter and the maximum
area of the segment were used as reference when calcu-
lating the relative reductions (Dred and Ared), in order
to get a more standardized and thus more reproducible
process. A limitation of our method is that the MaxD and
MaxA might be measured in a post-stenotic dilation,
which might lead to an overestimation of the degree of
the stenosis. On the other hand, the presence of post-
stenotic dilatations speaks in favor of hemodynamically
significant stenoses, and if they were considered when cal-
culating Dred and Ared, the correlations with CER + Ctest
might be better. Another limitation is the fact that we
measured stenosis using diameters and cross-sectional
areas only, thus ignoring the length of the stenosis, which
might also influence arterial blood flow.
When measuring vessels in a 3D dataset, the voxels
should be as small as possible and preferably close to
isotropic, i.e. have the same size in all three dimensions.
With the scanners we had available, this was not feasible,
and the MRA voxels (2.0×0.7×0.7 mm3) were larger than
the CTA voxels (0.75×0.5×0.5 mm3). The comparatively
thicker slices for MRA may have influenced the results
for MRA, in particular for Dred, which depends heavily
on a single diameter measurement. The poorer inter-
observer agreement in segment 2 as compared to seg-
ment 1 (Table 2) may also be related to the limited
spatial resolution.
The ideal method for determining the hemodynamical
significance of the stenosis in a clinical context would be to
evaluate the outcome of interventions such as PTRA, com-
plemented with information about loss of renal paren-
chyma. However, the effect of the intervention is
confounded by concurrent medical therapy, patient-related
preferences and costs [6]. We therefore considered it im-
practical to use the therapeutic outcome as the reference
method. IARA combined with measuring the pressure
drop over the stenosis would have been an interesting ref-
erence method since it has been shown to correlate with
the release of renin behind the stenosed kidney, thus a
good indicator of whether the stenosis contributes to
hypertension or not [11]. However, it has the obvious
drawback of being an invasive method and it is shown to
be associated with a risk of severe complications, including
cholesterol embolization, pseudoaneurysm, hematoma [7,
9], arteriovenous fistula and contrast-induced acute renal
failure [8, 10]. The presence of a catheter in the artery
might also alter the arterial fluid mechanisms, and thereby
disturb the measurements; however, using a smaller
pressure-sensing guidewire than the conventional catheter
might reduce the disturbances [12]. The risks of IARA with
measurement of the pressure gradient made it ethically un-
acceptable to perform an invasive catheterization in those
patients where the non-invasive diagnostic methods did
not indicate a stenosis, and it was therefore not included in
the study protocol. For the same ethical reasons, invasive
measurement of renin concentrations in the renal veins
[35] was also excluded. Duplex ultrasonography would be
another potential reference method. It has the advantage of
providing both morphologic and functional assessment of
the renal arteries, and it is a fast and inexpensive method,
but it is very dependent on the skill of the observer. There
are also difficulties in obtaining reproducible results from
different sites [18, 19]. Ultrasound was therefore not con-
sidered an optimal reference method for the study.
CER +Ctest was chosen because it is a well-known
method widely accepted for determining the hemodynamic
significance of the stenosis [36]. It has been reported to
have good sensitivity (87–95 %) and specificity (93–100 %)
for detecting RAS when the reference is whether there is a
reduction in blood pressure following intervention [20, 21],
suggesting that CER +Ctest is a good predictor of the
hemodynamic aspect of the stenosis. Its non-invasive na-
ture also makes it a less harmful procedure compared to
IARA. As the aim of the study was to investigate how dif-
ferent morphological measures of a stenosis correlate with
the hemodynamic significance, we considered CER +Ctest
to be the most suitable reference method. However, the
question might be raised whether CER +Ctest is the
optimum reference method in this study as the material
included patients with moderately reduced renal function
(serum creatinine of 150–300 μmol/L), where CER is less
sensitive [37]. The sensitivity for detecting RAS with CER
in patients with slightly to moderately reduced renal func-
tion has been reported between 75 and 87 % [38]. Pedersen
[36] draws the conclusion that ACE inhibitor renography
seems able to diagnose RAS in patients with reduced renal
function as long as the renal function is not severely im-
paired. Therefore, CER + Ctest was still considered the
most suitable reference method for our material des-
pite the moderately reduced renal function of the in-
cluded patients.
The lack of significance of the results in our study
could be explained by the small number of cases, espe-
cially the few positive cases (11 kidneys) on CER + Ctest.
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Such a small number of positives may give random vari-
ations a big impact and therefore results in wide confi-
dence intervals. Because no outlier analysis was made, a
few extreme measurements might have severe impacts
on the results.
Conclusion
No significant differences were found between different
morphological diameter and area measures in their abil-
ity to predict hemodynamically significant RAS. How-
ever, there is a non-significant tendency of MRA being a
better predictor than CTA with the area reduction in the
main artery as the best measurement. Automated mea-
surements with the interactive vessel segmentation soft-
ware showed very good reproducibility and only slightly
lower validity than the visually assessed measurements
in predicting the outcome of CER + Ctest, suggesting
that this segmentation tool might be useful in the diag-
nosis of RAS. Nevertheless, the diagnostic value of mor-
phological measures of renal artery stenosis is still
incompletely known, and further studies using larger
materials and scanners permitting higher spatial reso-
lution are needed.
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